Risk Factors and Prognosis in Patients with COVID-19 and Liver Injury: A Retrospective Analysis
- PMID: 33731999
- PMCID: PMC7956859
- DOI: 10.2147/JMDH.S293378
Risk Factors and Prognosis in Patients with COVID-19 and Liver Injury: A Retrospective Analysis
Abstract
Purpose: COVID-19 is a new infectious disease with global spread. The aim of the present study was to explore possible risk factors and evaluate prognosis in COVID-19 with liver injury.
Methods: A retrospective study was conducted on 356 COVID-19 patients in the Third People's Hospital of Yichang, Hubei, China. Clinical characteristics and laboratory tests between patients with and without liver injury were compared, while risk factors of COVID-19-related liver injury were analyzed. Univariate and multivariate Cox regression analyses were conducted to identify risk factors of in-hospital death.
Results: Of the patients with liver injury, severe and critical types of COVID-19 comprised 12.43% and 14.69%, respectively, higher than in patients without liver injury (both P<0.05). CRP and male sex were independent risk factors for for patients with liver injury, while decreased lymphocyte count (HR 0.024, 95% CI 0.001-0.821) and elevated monocytes (HR 1.951, 95% CI 1.040-3.662) and CRP (HR 1.028, 95% CI 1.010-1.045) were independent risk factors of prognosis of death in COVID-19 patients with liver injury.
Conclusion: Liver injury is a common complication in severe COVID-19 patients. Male sex and elevated CRP were independent risk factors in COVID-19 complicated by liver damage. Liver damage with increased CRP and monocyte count and decreased lymphocyte count may imply a poor prognosis.
Keywords: COVID-19; liver injury; prognosis; risk factors.
© 2021 Shen et al.
Conflict of interest statement
The authors state that they have no conflicts of interest regarding the content of this manuscript.
Figures
Similar articles
-
Analysis of influencing factors related to elevated serum troponin I level for COVID-19 patients in Yichang, China.Cardiovasc Diagn Ther. 2020 Aug;10(4):678-686. doi: 10.21037/cdt-20-510. Cardiovasc Diagn Ther. 2020. PMID: 32968624 Free PMC article.
-
Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China.World J Gastroenterol. 2021 Mar 7;27(9):835-853. doi: 10.3748/wjg.v27.i9.835. World J Gastroenterol. 2021. PMID: 33727773 Free PMC article.
-
Clinical Characteristics and Risk Factors in Coronavirus Disease 2019 Patients with Liver Injury.Med Sci Monit. 2020 Dec 19;26:e928849. doi: 10.12659/MSM.928849. Med Sci Monit. 2020. PMID: 33339813 Free PMC article.
-
The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.Clin Chem Lab Med. 2020 Jun 25;58(7):1106-1115. doi: 10.1515/cclm-2020-0377. Clin Chem Lab Med. 2020. PMID: 32352397
-
Liver damage at admission is an independent prognostic factor for COVID-19.J Dig Dis. 2020 Sep;21(9):512-518. doi: 10.1111/1751-2980.12925. J Dig Dis. 2020. PMID: 32713118
Cited by
-
Liver function as a predictor of mortality in COVID-19: A retrospective study.Ann Hepatol. 2021 Dec;26:100553. doi: 10.1016/j.aohep.2021.100553. Epub 2021 Oct 6. Ann Hepatol. 2021. PMID: 34624543 Free PMC article.
-
Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19.World J Hepatol. 2021 Dec 27;13(12):2005-2012. doi: 10.4254/wjh.v13.i12.2005. World J Hepatol. 2021. PMID: 35070004 Free PMC article. Review.
-
Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications.Hepatol Forum. 2024 Jul 2;5(3):139-149. doi: 10.14744/hf.2023.2023.0025. eCollection 2024. Hepatol Forum. 2024. PMID: 39006140 Free PMC article. Review.
-
Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments.World J Gastroenterol. 2023 Jan 14;29(2):241-256. doi: 10.3748/wjg.v29.i2.241. World J Gastroenterol. 2023. PMID: 36687127 Free PMC article. Review.
-
Liver Injury Associated with COVID-19 Infection: Pathogenesis, Histopathology, Prognosis, and Treatment.J Clin Med. 2023 Mar 6;12(5):2067. doi: 10.3390/jcm12052067. J Clin Med. 2023. PMID: 36902854 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous